Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06354465
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-03-31
Brief Title:
Injectable Extended-Release Buprenorphine XR-B in a Correctional Setting Qualitative Interviews
Sponsor:
Lifespan
Organization:
Lifespan
Study Overview
Official Title:
Injectable Extended-Release Buprenorphine XR-B in a Correctional Setting Qualitative Interviews
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This qualitative study investigates the potential benefits and challenges of using a once-a-month injectable medication known as extended-release buprenorphine XR-B to treat individuals with opioid use disorder OUD within a correctional setting The research aims to understand if XR-B can be a feasible and effective alternative to the standard daily treatment and to identify which groups within the prison population may benefit the most from this treatment In-depth interviews are conducted with incarcerated individuals and relevant stakeholders
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K23DA055695 | NIH | None | httpsreporternihgovquickSearchK23DA055695 |